In a new study in Nature Communications, researchers from around India have suggested that the key to outsmarting the ...
Pelareorep combined with standard chemotherapy achieved a 33% objective response rate in KRAS-mutant MSS mCRC, surpassing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback